SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
viral / blood*
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
13
1
Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis
2
The acquisition of herpes simplex virus during pregnancy
3
Herpes simplex virus type 2 in the United States, 1976 to 1994
4
Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples
5
Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers
6
Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement
7
Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens
8
Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2
9
Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population
10
Testing for type-specific antibody to herpes simplex virus--implications for clinical practice
11
Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion
12
Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection
13
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial